Suzuki Tsuyoshi, Shiga Tsuyoshi, Wakaumi Michi, Matsuda Naoki, Ishizuka Naoko, Kasanuki Hiroshi
Department of Cardiology, Heart Institute of Japan, Tokyo Women's Medical University, Kawada-cho 8-1, Shinjuku-ku, Tokyo 162-8666.
J Cardiol. 2003 Apr;41(4):169-73.
Nonischemic heart disease, especially idiopathic dilated cardiomyopathy, is relatively common among Japanese patients receiving amiodarone for concomitant ventricular arrhythmia, but the hemodynamic effects of amiodarone in these Japanese patients are unclear. The hemodynamic changes during chronic amiodarone administration were retrospectively studied in patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia.
Fifty-two patients [42 males, 10 females, 53 +/- 2 years (mean age +/- SE)] with ventricular tachyarrhythmia and idiopathic dilated cardiomyopathy with left ventricular ejection fraction of 27 +/- 1% (mean +/- SE) were treated with 200-400 mg daily of oral amiodarone as the loading dose for the initial 14 days and 100-200 mg daily maintenance dose for a further 6 months. No patients were taking beta-blockers or positive inotropic drugs. Echocardiographic examination was performed before (baseline), at week 2 and at month 6 of amiodarone therapy. Twenty four-hour Holter monitoring during the same time period was also performed in 34 patients. Seventeen patients underwent right heart catheterization before and at week 2.
Echocardiographic measurements showed no significant change in left ventricular end-diastolic dimension, although there was a slight increase in fractional shortening from 16 +/- 1% to 19 +/- 1% (p < 0.05) and 18 +/- 1% (mean +/- SE) (p < 0.01) at week 2 and month 6 of amiodarone therapy, respectively. Amiodarone markedly reduced the mean heart rate and the frequency of premature ventricular complexes on ambulatory monitoring. The cardiac index did not change and the pulmonary capillary wedge pressure tended to decrease slightly at week 2 in the 17 patients who underwent catheterization.
This retrospective study showed no worsening of the hemodynamic state during chronic amiodarone administration in Japanese patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia.
在接受胺碘酮治疗合并室性心律失常的日本患者中,非缺血性心脏病,尤其是特发性扩张型心肌病较为常见,但胺碘酮对这些日本患者的血流动力学影响尚不清楚。我们对特发性扩张型心肌病合并室性心律失常患者在长期服用胺碘酮期间的血流动力学变化进行了回顾性研究。
52例室性快速心律失常和特发性扩张型心肌病患者[42例男性,10例女性,年龄53±2岁(平均年龄±标准误)],左心室射血分数为27±1%(平均±标准误),在最初14天给予每日200 - 400mg口服胺碘酮作为负荷剂量,随后6个月给予每日100 - 200mg维持剂量。无患者服用β受体阻滞剂或正性肌力药物。在胺碘酮治疗前(基线)、第2周和第6个月进行超声心动图检查。同期34例患者还进行了24小时动态心电图监测。17例患者在治疗前和第2周进行了右心导管检查。
超声心动图测量显示左心室舒张末期内径无显著变化,尽管在胺碘酮治疗第2周和第6个月时,缩短分数分别从16±1%轻微增加至19±1%(p<0.05)和18±1%(平均±标准误)(p<0.01)。胺碘酮显著降低了动态监测时的平均心率和室性早搏频率。在接受导管检查的17例患者中,第2周时心脏指数未改变,肺毛细血管楔压有轻微下降趋势。
这项回顾性研究表明,在患有特发性扩张型心肌病和室性心律失常的日本患者中,长期服用胺碘酮期间血流动力学状态没有恶化。